Media coverage
20
Media coverage
Title Receives FDA Approval to Begin Study with Selective Cytopheretic Device to Reduce Hyperinflammation in Adults with Acute Kidney Injury Media name/outlet Market News Publishing Country/Territory United States Date 10/02/23 Persons Kevin Chung Title SeaStar Medical Receives FDA Approval to Begin Study with Selective Cytopheretic Device to Reduce Hyperinflammation in Adults with Acute Kidney Injury Media name/outlet Morningstar.com Country/Territory United States Date 9/02/23 URL https://www.morningstar.com/news/globe-newswire/8746207/seastar-medical-receives-fda-approval-to-begin-study-with-selective-cytopheretic-device-to-reduce-hyperinflammation-in-adults-with-acute-kidney-injury Persons Kevin Chung Title SeaStar Medical Receives FDA Approval to Begin Study with Selective Cytopheretic Device to Reduce Hyperinflammation in Adults with Acute Kidney Injury Media name/outlet Street Insider Country/Territory United States Date 9/02/23 URL https://www.streetinsider.com/Press+Releases/SeaStar+Medical+Receives+FDA+Approval+to+Begin+Study+with+Selective+Cytopheretic+Device+to+Reduce+Hyperinflammation+in+Adults+with+Acute+Kidney+Injury/21186846.html Persons Kevin Chung Title SeaStar Medical Receives FDA Approval to Begin Study with Selective Cytopheretic Device to Reduce Hyperinflammation in Adults with Acute Kidney Injury Media name/outlet BioSpace Country/Territory United States Date 9/02/23 URL https://www.biospace.com/article/releases/seastar-medical-receives-fda-approval-to-begin-study-with-selective-cytopheretic-device-to-reduce-hyperinflammation-in-adults-with-acute-kidney-injury/ Persons Kevin Chung Title SeaStar Medical Receives FDA Approval to Begin Study with Selective Cytopheretic Device to Reduce Hyperinflammation in Adults with Acute Kidney Injury Media name/outlet InvestorsObserver Country/Territory United States Date 9/02/23 URL https://www.investorsobserver.com/news/qm-pr/8692399026452888 Persons Kevin Chung Title SeaStar Medical Receives FDA Approval to Begin Study with Selective Cytopheretic Device to Reduce Hyperinflammation in Adults with Acute Kidney Injury Media name/outlet Yahoo! News Country/Territory United States Date 9/02/23 URL https://www.yahoo.com/now/seastar-medical-receives-fda-approval-131900217.html Persons Kevin Chung Title SeaStar Medical Receives FDA Approval to Begin Study with Selective Cytopheretic Device to Reduce Hyperinflammation in Adults with Acute Kidney Injury Media name/outlet Yahoo! Finanzas Country/Territory United States Date 9/02/23 URL https://es-us.finanzas.yahoo.com/news/seastar-medical-receives-fda-approval-131900217.html Persons Kevin Chung Title SeaStar Medical Receives FDA Approval to Begin Study with Selective Cytopheretic Device to Reduce Hyperinflammation in Adults with Acute Kidney Injury Media name/outlet Yahoo! Finance Country/Territory United States Date 9/02/23 URL https://finance.yahoo.com/news/seastar-medical-receives-fda-approval-131900217.html Persons Kevin Chung Title SeaStar Medical Receives FDA Approval to Begin Study with Selective Cytopheretic Device to Reduce Hyperinflammation in Adults with Acute Kidney Injury Media name/outlet Stockwatch Country/Territory Canada Date 9/02/23 URL www.stockwatch.com/News/Item/U-z8746207-U!ICU-20230209/U/ICU Persons Kevin Chung Title SeaStar Medical Receives FDA Approval to Begin Study with Selective Cytopheretic Device to Reduce Hyperinflammation in Adults with Acute Kidney Injury Media name/outlet ADVFN US Country/Territory United States Date 9/02/23 URL https://www.advfn.com/p.php?pid=nmona&article=90190140 Persons Kevin Chung Title SeaStar Medical Receives FDA Approval to Begin Study with Selective Cytopheretic Device to Reduce Hyperinflammation in Adults with Acute Kidney Injury Media name/outlet Market Newsdesk Country/Territory United States Date 9/02/23 URL https://www.marketnewsdesk.com/index.php/seastar-medical-receives-fda-approval-to-begin-study-with-selective-cytopheretic-device-to-reduce-hyperinflammation-in-adults-with-acute-kidney-injury/ Persons Kevin Chung Title SeaStar Medical Receives FDA Approval to Begin Study with Selective Cytopheretic Device to Reduce Hyperinflammation in Adults with Acute Kidney Injury Media name/outlet Spoke.com Country/Territory United States Date 9/02/23 URL https://www.spoke.com/press_releases/63e4f9b6fc12b05fed00868e Persons Kevin Chung Title SeaStar Medical Receives FDA Approval to Begin Study with Selective Cytopheretic Device to Reduce Hyperinflammation in Adults with Acute Kidney Injury Media name/outlet Health Technology Net Country/Territory United States Date 9/02/23 URL healthtechnologynet.com/2023/02/09/seastar-medical-receives-fda-approval-to-begin-study-with-selective-cytopheretic-device-to-reduce-hyperinflammation-in-adults-with-acute-kidney-injury/ Persons Kevin Chung Title SeaStar Medical Receives FDA Approval to Begin Study with Selective Cytopheretic Device to Reduce Hyperinflammation in Adults with Acute Kidney Injury Media name/outlet GlobeNewswire Country/Territory United States Date 9/02/23 URL https://www.globenewswire.com/news-release/2023/02/09/2604995/0/en/SeaStar-Medical-Receives-FDA-Approval-to-Begin-Study-with-Selective-Cytopheretic-Device-to-Reduce-Hyperinflammation-in-Adults-with-Acute-Kidney-Injury.html Persons Kevin Chung Title SeaStar Medical Receives FDA Approval to Begin Study with Selective Cytopheretic Device to Reduce Hyperinflammation in Adults with Acute Kidney Injury Media name/outlet PrimeNewswire (Top News) Country/Territory United States Date 9/02/23 Persons Kevin Chung Title SeaStar Medical Receives FDA Approval to Begin Study with Selective Cytopheretic Device to Reduce Hyperinflammation in Adults with Acute Media name/outlet Port Arthur News Country/Territory United States Date 9/02/23 URL https://smb.panews.com/article/SeaStar-Medical-Receives-FDA-Approval-to-Begin-Study-with-Selective-Cytopheretic-Device-to-Reduce-Hyperinflammation-in-Adults-with-Acute-Kidney-Injury?storyId=63e4f39ba0bab101235b4d04 Persons Kevin Chung Title SeaStar Medical Receives FDA Approval to Begin Study with Selective Cytopheretic Device to Reduce Hyperinflammation in Adults with Acute Media name/outlet Winchester Sun Country/Territory United States Date 9/02/23 URL https://smb.winchestersun.com/article/SeaStar-Medical-Receives-FDA-Approval-to-Begin-Study-with-Selective-Cytopheretic-Device-to-Reduce-Hyperinflammation-in-Adults-with-Acute-Kidney-Injury?storyId=63e4f39ba0bab101235b4d04 Persons Kevin Chung Title SeaStar Medical Receives FDA Approval to Begin Study with Selective Cytopheretic Device to Reduce Hyperinflammation in Adults with Acute Media name/outlet Smithfield Times Country/Territory United States Date 9/02/23 URL https://smb.smithfieldtimes.com/article/SeaStar-Medical-Receives-FDA-Approval-to-Begin-Study-with-Selective-Cytopheretic-Device-to-Reduce-Hyperinflammation-in-Adults-with-Acute-Kidney-Injury?storyId=63e4f39ba0bab101235b4d04 Persons Kevin Chung Title SeaStar Medical Receives FDA Approval to Begin Study with Selective Cytopheretic Device to Reduce Hyperinflammation in Adults with Acute Media name/outlet Jessamine Journal Country/Territory United States Date 9/02/23 URL https://smb.jessaminejournal.com/article/SeaStar-Medical-Receives-FDA-Approval-to-Begin-Study-with-Selective-Cytopheretic-Device-to-Reduce-Hyperinflammation-in-Adults-with-Acute-Kidney-Injury?storyId=63e4f39ba0bab101235b4d04 Persons Kevin Chung Title SeaStar Medical Receives FDA Approval to Begin Study with Selective Cytopheretic Device to Reduce Hyperinflammation in Adults with Acute Media name/outlet Suffolk News Herald Country/Territory United States Date 9/02/23 URL https://smb.suffolknewsherald.com/article/SeaStar-Medical-Receives-FDA-Approval-to-Begin-Study-with-Selective-Cytopheretic-Device-to-Reduce-Hyperinflammation-in-Adults-with-Acute-Kidney-Injury?storyId=63e4f39ba0bab101235b4d04 Persons Kevin Chung